Arcadia Biosciences Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director election, stock issuance, equity plan, reverse split, executive compensation, and auditor ratification. All proposals passed by majority vote, and no shareholder questions were submitted.
Fiscal Year 2025
-
Zola sales surged 90% year-over-year in Q1 2025, outpacing the coconut water category and driving a 22% revenue increase. The company exited its legacy agtech business, monetized IP, and reduced liabilities, while the Roosevelt Resources merger remains on track for completion by August.
Fiscal Year 2024
-
2024 saw a strategic refocus on Zola coconut water, driving 46% sales growth and record distribution gains, while exiting underperforming brands and monetizing legacy assets. Gross margins remained strong, and the Roosevelt Resources transaction is expected to close by Q2 2025.
-
Arcadia will issue shares to acquire Roosevelt, resulting in Roosevelt owning 90% of the combined entity. The deal enables Roosevelt to advance its large-scale CCUS and EOR project, with the company renamed Roosevelt Resources and led by Roosevelt’s management.
-
Q3 2024 saw 18% revenue growth, led by a 55% increase in Zola sales and major distribution gains. Cash burn hit historic lows, and Zola outpaced the coconut water category, with new product launches planned for next year.
-
Q2 2024 marked a strategic shift, with wheat IP monetization and GoodWheat exit fueling cost savings and a focus on Zola Coconut Water, which saw 42% sales growth. Revenues are expected to match 2023, with gross margins in the low 40s and cash burn halved.